With GLP-1 treatments clinically proven to help reduce up to 20% of your body fat, book in a consultation with us today to begin your weight loss journey.
Injectable GLP-1 treatments are medicines that come in a pre-filled pen that are self-administered at home once a week. GLP-1 treatments mimic a natural hormone in your gut. It regulates your blood sugar levels and keeps you feeling full for longer.
Initial Consultation Fee – £50 which includes height, weight, BMI and Blood Pressure.
Dose | Use | Price |
---|---|---|
0.25mg (starting dose) | Weeks 1 – 4 | £155 |
0.5mg | Weeks 5 - 8 | £155 |
1mg | Weeks 9 - 12 | £155 |
1.7mg | Weeks 13 – 16 | £260 |
2.4mg | Week 17 onward | £260 |
We also offer a starter weight loss package for £275 this includes:
Consultation, height, weight, BMI, Blood Pressure, Blood tests: HbA1C, Cholesterol Levels, Sharps Box, and starter pack medication
You will be required to undergo 3 monthly reviews at our clinic to ensure consistent weight loss and to avoid any complications. Reviews are charged at £50. No medications will be issued unless this review is complete.
Significant Weight Loss: Clinical trials have demonstrated that Wegovy can lead to substantial weight loss, with participants achieving an average reduction of 15-20% of their initial body weight.
Improved Metabolic Health: In addition to weight loss, Wegovy has been shown to improve various metabolic parameters, including glycaemic control, blood pressure, and lipid profiles, which can reduce the risk of obesity-related complications.
Long-Term Sustainability: Unlike many weight loss interventions that yield short-term results, Wegovy offers the potential for sustained weight loss and maintenance, providing patients with a viable long-term solution.
Side Effects: While generally well-tolerated, common side effects of Wegovy include nausea, diarrhoea, vomiting, and constipation, particularly during the dose escalation phase. These symptoms typically diminish over time.
Contraindications: Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, as well as those with a history of pancreatitis.
Pregnancy and Lactation: The safety of Wegovy during pregnancy and breastfeeding has not been established. Therefore, it should be used with caution in women of reproductive age, and contraception should be ensured during treatment.
Start your weight loss journey and book a consultation to see if you would be suitable for the treatment:
117 Saltmarket
Glasgow
G1 5LF
clinic@medassistant.co.uk
Telephone: 0141 255 2681